Gene expression in tumor cells and stroma in dsRed 4T1 tumors in eGFP-expressing mice with and without enhanced oxygenation

BMC Cancer

Volumn 12, Issue , 2012, Pages

  Moen, Ingrid ^a   Jevne, Charlotte ^a   Wang, Jian ^a   Kalland, Karl Henning ^a,b   Chekenya, Martha ^a   Akslen, Lars A ^a,b   Sleire, Linda ^a   Enger, Per T ^a   Reed, Rolf K ^a   Øyan, Anne M ^a,b   Stuhr, Linda E B ^a  

^a UNIVERSITY OF BERGEN   (Norway)

^b HAUKELAND UNIVERSITY HOSPITAL   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

MITOGEN ACTIVATED PROTEIN KINASE; GREEN FLUORESCENT PROTEIN; MATRIX METALLOPROTEINASE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CANCER INHIBITION; CANCER MORPHOLOGY; CELL INTERACTION; CELL PROLIFERATION; CONTROLLED STUDY; FEMALE; FLUORESCENCE ACTIVATED CELL SORTING; FLUORESCENCE MICROSCOPY; GENE EXPRESSION; GENE EXPRESSION PROFILING; HISTOPATHOLOGY; HYPERBARIC OXYGEN; HYPEROXIA; IMMUNOHISTOCHEMISTRY; IN VIVO STUDY; MICROVASCULATURE; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; STROMA CELL; TUMOR CELL; TUMOR GROWTH; TUMOR MICROENVIRONMENT; TUMOR VASCULARIZATION; UNINDEXED SEQUENCE; ANIMAL; CELL HYPOXIA; DRUG EFFECT; EXPERIMENTAL NEOPLASM; EXTRACELLULAR MATRIX; GENETICS; METABOLISM; MOUSE MUTANT; NONOBESE DIABETIC MOUSE; PATHOLOGY; PHYSIOLOGY; TUMOR CELL LINE;

ANIMALS; CELL HYPOXIA; CELL LINE, TUMOR; CELL PROLIFERATION; EXTRACELLULAR MATRIX; FEMALE; GENE EXPRESSION PROFILING; GREEN FLUORESCENT PROTEINS; HYPERBARIC OXYGENATION; MAMMARY NEOPLASMS, EXPERIMENTAL; MATRIX METALLOPROTEINASES; MICE; MICE, INBRED NOD; MICE, SCID;

EID: 84855789325     PISSN: None     EISSN: 14712407     Source Type: Journal    
DOI: 10.1186/1471-2407-12-21     Document Type: Article

References (26)

1. Witz IP. The tumor microenvironment: the making of a paradigm. Cancer Microenviron 2009, 2(Suppl 1):9-17. 2756342,2756342, 19701697.
2. Fukumura D, Xavier R, Sugiura T, Chen Y, Park EC, Lu N, Selig M, Nielsen G, Taksir T, Jain RK, et al. Tumor induction of VEGF promoter activity in stromal cells. Cell 1998, 94(6):715-725. 10.1016/S0092-8674(00)81731-6, 9753319.
3. Fukumura D, Yuan F, Monsky WL, Chen Y, Jain RK. Effect of host microenvironment on the microcirculation of human colon adenocarcinoma. Am J Pathol 1997, 151(3):679-688. 1857859, 9284816.
4. Hobbs SK, Monsky WL, Yuan F, Roberts WG, Griffith L, Torchilin VP, Jain RK. Regulation of transport pathways in tumor vessels: role of tumor type and microenvironment. Proc Natl Acad Sci USA 1998, 95(8):4607-4612. 10.1073/pnas.95.8.4607, 22537, 9539785.
5. Langley RR, Fidler IJ. Tumor cell-organ microenvironment interactions in the pathogenesis of cancer metastasis. Endocr Rev 2007, 28(3):297-321. 10.1210/er.2006-0027, 17409287.
6. Niclou SP, Danzeisen C, Eikesdal HP, Wiig H, Brons NH, Poli AM, Svendsen A, Torsvik A, Enger PO, Terzis JA, et al. A novel eGFP-expressing immunodeficient mouse model to study tumor-host interactions. FASEB J 2008, 22(9):3120-3128. 10.1096/fj.08-109611, 2518261, 18495755.
7. Harris AL. Hypoxia- a key regulatory factor in tumor growth. Nat Rev Cancer 2002, 2:38-47. 10.1038/nrc704, 11902584.
8. Gray LH, Conger AD, Ebert M, Hornsey S, Scott OC. The concentration of oxygen dissolved in tissues at the time of irradiation as a factor in radiotherapy. Br J Radiol 1953, 26(312):638-648. 10.1259/0007-1285-26-312-638, 13106296.
9. Thomlinson RH, Gray LH. The histological structure of some human lung cancers and the possible implications for radiotherapy. Br J Cancer 1955, 9(4):539-549. 10.1038/bjc.1955.55, 2073776, 13304213.
10. Teicher BA. Hypoxia and drug resistance. Cancer Metastasis Rev 1994, 13(2):139-168. 10.1007/BF00689633, 7923547.
11. Harrison L, Blackwell K. Hypoxia and anemia: factors in decreased sensitivity to radiation therapy and chemotherapy?. Oncologist 2004, 9(Suppl 5):31-40.
12. Stuhr LE, Iversen VV, Straume O, Maehle BO, Reed RK. Hyperbaric oxygen alone or combined with 5-FU attenuates growth of DMBA-induced rat mammary tumors. Cancer Lett 2004, 210(1):35-40. 10.1016/j.canlet.2004.02.012, 15172118.
13. Stuhr LE, Raa A, Oyan AM, Kalland KH, Sakariassen PO, Petersen K, Bjerkvig R, Reed RK. Hyperoxia retards growth and induces apoptosis, changes in vascular density and gene expression in transplanted gliomas in nude rats. J Neurooncol 2007, 85(2):191-202. 10.1007/s11060-007-9407-2, 17557137.
14. Moen I, Oyan AM, Kalland KH, Tronstad KJ, Akslen LA, Chekenya M, Sakariassen PO, Reed RK, Stuhr LE. Hyperoxic treatment induces mesenchymal-to-epithelial transition in a rat adenocarcinoma model. PLoS One 2009, 4(7):e6381. 10.1371/journal.pone.0006381, 2712688, 19636430.
15. Moen I, Tronstad KJ, Kolmannskog O, Salvesen GS, Reed RK, Stuhr LE. Hyperoxia increases the uptake of 5-fluorouracil in mammary tumors independently of changes in interstitial fluid pressure and tumor stroma. BMC Cancer 2009, 9(1):446. 10.1186/1471-2407-9-446, 2805681, 20017908.
16. Raa A, Stansberg C, Steen VM, Bjerkvig R, Reed RK, Stuhr L. Hyperoxia retards growth and induces apoptosis and loss of glands and blood vessels in DMBA-induced rat mammary tumors. BMC Cancer 2007, 7:23. 10.1186/1471-2407-7-23, 1797183, 17263869.
17. Gill AL, Bell CNA. Hyperbaric oxygen: its uses, mechanisms of action and outcomes. QJM 2004, 97:385-395. 10.1093/qjmed/hch074, 15208426.
18. Dexter DL, Kowalski HM, Blazar BA, Fligiel Z, Vogel R, Heppner GH. Heterogeneity of tumor cells from a single mouse mammary tumor. Cancer Res 1978, 38(10):3174-3181.
19. Dysvik B, Jonassen I. J-express: exploring gene expression data using Java. Bioinformatics 2001, 17(4):369-370. 10.1093/bioinformatics/17.4.369, 11301307.
20. Subramanian A, Tamayo P, Mootha VK, Mukherjee S, Ebert BL, Gillette MA, Paulovich A, Pomeroy SL, Golub TR, Lander ES, et al. Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc Natl Acad Sci USA 2005, 102(43):15545-15550. 10.1073/pnas.0506580102, 1239896, 16199517.
21. Jevne CMI, Salvesen G, Reed RK, Stuhr LEB. A reduction in the interstitial fluid pressure per se, does not enhance the uptake of the small molecule weight compound 5-fluorouracil into 4T1 mammary tumours. Drug and Therapy Studies 2011, 1(1):10-14.
22. Radisky ES, Radisky DC. Stromal induction of breast cancer: inflammation and invasion. Rev Endocr Metab Disord 2007, 8(3):279-287. 10.1007/s11154-007-9037-1, 17447144.
23. Sorlie T, Perou CM, Tibshirani R, Aas T, Geisler S, Johnsen H, Hastie T, Eisen MB, van de Rijn M, Jeffrey SS, et al. Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications. Proc Natl Acad Sci USA 2001, 98(19):10869-10874. 10.1073/pnas.191367098, 58566, 11553815.
24. Dhillon AS, Hagan S, Rath O, Kolch W. MAP kinase signalling pathways in cancer. Oncogene 2007, 26(22):3279-3290. 10.1038/sj.onc.1210421, 17496922.
25. Tao K, Fang M, Alroy J, Sahagian GG. Imagable 4T1 model for the study of late stage breast cancer. BMC Cancer 2008, 8:228. 10.1186/1471-2407-8-228, 2529338, 18691423.
26. Haroon AT, Patel M, Al-Mehdi AB. Lung metastatic load limitation with hyperbaric oxygen. Undersea Hyperb Med 2007, 34(2):83-90.